SG

Shailesh Gangaram Kamble

Active Director Director DIN 09808032
DIN 09808032 First appointment Nov 2022 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Shailesh Gangaram Kamble

Data last updated:

Shailesh Gangaram Kamble is a Director at Koshing Pharma India Private Limited (since 2022). The company operates in Food And Beverages.

DIN 09808032
Primary Designation Director
Industry Food And Beverages
First Appointment 30 Nov 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Koshing Pharma India Private Limited U24304MH2022PTC394368
Director30 Nov 20222022Active

Board colleagues of Shailesh Gangaram Kamble

Directorship timeline

Open interactive timeline →
Koshing Pharma India Private Limited
Premium access

Shareholding and investment profile for Shailesh Gangaram Kamble

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shailesh Gangaram Kamble

Shailesh Gangaram Kamble currently holds 1 directorship: Koshing Pharma India Private Limited (Director, since 30 Nov 2022).

Shailesh Gangaram Kamble was first appointed on 30 Nov 2022 as Director at Koshing Pharma India Private Limited.

The current boards of Shailesh Gangaram Kamble's companies include Dhananjay Keshav Gayakwad (Koshing Pharma India Private Limited), Kiran Harichandra Jadhav (Koshing Pharma India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available